Article Text

Download PDFPDF
  1. E J Adams1,
  2. K M E Turner2
  1. 1Modelling and Economics Unit, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London, UK;
  2. 2Imperial University, London, UK

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    How much does chlamydia screening cost and is it worth introducing? That is, will the savings from future disease averted offset the screening costs (will it be cost saving?), and if it will not, is the extra health “bought” by screening worth it, in terms of alternative uses of the same resources? Here, Roberts et al1 provide a valuable critique of the literature on the cost effectiveness of chlamydia screening. Despite a large body of published work, their paper highlights the lack of appropriate methods used in the majority of previous studies.

    To correctly model the full effects of screening for an infectious disease like chlamydia (including …

    View Full Text